Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-02-06 @ 6:53 AM
Study NCT ID:
NCT04915404
Status:
TERMINATED
Last Update Posted:
2024-06-06
First Post:
2021-02-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
Sponsor:
WPD Pharmaceuticals Sp. z o.o.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-23
First Submit QC Date:
None
Study First Post Date:
2021-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-03
Last Update Post Date:
2024-06-06
Last Update Post Date Type:
ACTUAL